MariMed Receives Approval to Once Again Produce and Sell HighDosage Edibles in Maryland

NORWOOD, Mass., April 04, 2023 (GLOBE NEWSWIRE) — MariMed Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator, today announced that its wholly owned subsidiary, Kind Therapeutics USA, has received approval from the Maryland Medical Cannabis Commission (“MMCC”) to immediately begin producing and distributing higher-dosage, THC-infused edibles. Maryland cannabis regulations changed in 2021, imposing a THC limit of 10 milligrams per edible serving unless the product was produced and distributed from a Good Manufacturing Practice (“GMP”) certified kitchen. GMP certification is a process conducted by third-party auditors that ensures a commercial kitchen and the products…